Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC
| Autor: | Drilon, Alexander a, Chiu, Chao-Hua b, Fan, Yun c, Cho, Byoung Chul d, Lu, Shun e, Ahn, Myung-Ju f, Krebs, Matthew G. g, Liu, Stephen V. h, John, Thomas i, Otterson, Gregory A. j, Tan, Daniel S.W. k, Patil, Tejas l, Dziadziuszko, Rafal m, Massarelli, Erminia n, Seto, Takashi o, Doebele, Robert C. l, Pitcher, Bethany p, Kurtsikidze, Nino q, Heinzmann, Sebastian r, Siena, Salvatore r, s, ∗ |
|---|---|
| Zdroj: | In JTO Clinical and Research Reports June 2022 3(6) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|